Description: Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. It operates through Pharmaceuticals, and Wholesale and Retail segments. The company focuses on the development and manufacture of products in various therapeutic areas, including gynecological, cardiovascular, and central nervous system. Its gynecological products include contraceptives, emergency contraceptives, hormone replacements, fungicides, and preparations used for the treatment of uterine fibroids. The company also offers central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, it produces various over-the-counter products for various health problems comprising Escapelle (Postinor), an emergency contraceptive pill; Panangin for supporting cardiovascular health; Stopdiar to treat diarrhea; Lordestin and Zilola for allergy; and Curiosin for wound care. The company was founded in 1901 and is headquartered in Budapest, Hungary.
Home Page: www.gedeonrichter.com/hu-hu
Gyömroi út 19-21.
Budapest,
1103
Hungary
Phone:
36 1 431 4000
Officers
Name | Title |
---|---|
Mr. Gabor Orban | CEO, Member of Executive Board & Director |
Mr. Istvan Hamecz | CFO, Member of Executive Board & Director |
Dr. Istvan Greiner | R&D Director and Member of Executive Board |
Ms. Katalin Erdei | HR Director & Member of Executive Board |
Attila Szenasi | COO & Member of the Executive Board |
Mr. Tamas Szolyak | Director of Global Regulatory Science and Portfolio Management & Member of Executive Board |
Mr. Robert Rethy | Head of the Investor Relations & ESG Department |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 7.2886 |
---|---|
Trailing PE: | 7.8764 |
Price-to-Book MRQ: | 1.5326 |
Price-to-Sales TTM: | 0.0065 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 11603 |